Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Experimental Neuroscience|May 16, 2018
Tau: A Common Denominator and Therapeutic Target for Neurodegenerative DisordersAlexander Maxan, Francesca Cicchetti
Medical Hypotheses|March 13, 2016
Therapeutic iron restriction in sepsisYanfang Xia, Nizam Farah, Alexander Maxan, et al.
Clinical Hemorheology and Microcirculation|June 10, 2017
Tetrahydrobiopterin improves microcirculation in experimental sepsisTristan C Dumbarton, Alexander Maxan, Nizam Farah, et al.
Brain : a Journal of Neurology|October 26, 2017
Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's diseaseGiulia Cisbani, Alexander Maxan, Jeffrey H Kordower, et al.
Clinical Hemorheology and Microcirculation|September 18, 2014
Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shockJordan Nantais, Tristan C Dumbarton, Nizam Farah, et al.
Neurobiology of Disease|May 29, 2024
Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington's disease casesShireen Salem, Mitchell D Kilgore, Mehwish Anwer, et al.
Acta Neuropathologica|February 22, 2019
Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigmsMaria Masnata, Giacomo Sciacca, Alexander Maxan, et al.
Neurobiology of Disease|May 19, 2020
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primatesPhilippe Gosset, Alexander Maxan, Melanie Alpaugh, et al.
Neurobiology of Disease|May 15, 2020
Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's diseaseStefan Bartl, Abid Oueslati, Amber L Southwell, et al.
Pageof 2